Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    1 - 142 out of 142Page size: 500
    1. 2023
    2. Published

       of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

      Hulen, T. M., Friese, C., Kristensen, N. P., Granhøj, J. S., Borch, T. H., Peeters, M. J. W., Donia, M., Andersen, Mads Hald, Hadrup, S. R., Svane, Inge Marie & Met, Özcan, 2023, In: Frontiers in Immunology. 14, 15 p., 1180997.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial

      Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., Fassi, Daniel El , Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1117466.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Antibodies to calnexin and mutated calreticulin are common in human sera

      Kyllesbech, C., Trier, N. H., Mughal, F. P., Hansen, Paul Robert, Holmström, M. O., Fassi, Daniel El , Hasselbalch, H., Skov, V., Kjær, L., Andersen, Mads Hald, Ciplys, E., Slibinskas, R., Fredriksen, Jette Lautrup, Højrup, P. & Houen, G., 2023, In: Current Research in Translational Medicine. 71, 2, 103380.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

      Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., thor Straten, P. & 2 others, Andersen, Mads Hald & Svane, Inge Marie, 2023, In: Frontiers in Immunology. 14, 1122977.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Immune modulatory vaccines: time to move into infectious diseases

      Andersen, Mads Hald, 2023, In: The Lancet Microbe. 4, 1, p. e4-e5

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    7. Published

      Novel immune modulatory vaccines targeting TGFβ

      Andersen, Mads Hald, 2023, In: Cellular and Molecular Immunology. 20, p. 551–553

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    8. Published

      Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment

      Andersen, Mads Hald, 2023, In: Seminars in Immunopathology. 45, 2, p. 159-161 3 p.

      Research output: Contribution to journal › Editorial › Research › peer-review

    9. Published

      Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

      Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

      Hasselbalch, Hans Carl, Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, Morten Kranker, Holmström, M. O., Andersen, Mads Hald, Jensen, C., Karsdal, M. A. & Willumsen, N., 2023, In: Cancers. 15, 17, 47 p., 4323.

      Research output: Contribution to journal › Review › Research › peer-review

    11. Published

      Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

      Holmström, M. O., Andersen, M., Traynor, S., Ahmad, S. M., Lisle, T. L., Handlos Grauslund, J., Skov, V., Kjær, L., Ottesen, J. T., Gjerstorff, M. F., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1240678.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      Tumor microenvironment antigens

      Andersen, Mads Hald, 2023, In: Seminars in Immunopathology. 45, p. 253–264

      Research output: Contribution to journal › Review › Research › peer-review

    13. 2022
    14. Published

      Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

      Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

      Research output: Contribution to journal › Journal article › Research › peer-review

    15. Published

      Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

      Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.

      Research output: Contribution to journal › Journal article › Research › peer-review

    16. Published

      Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

      Weis-Banke, S. E., Lisle, T. L., Perez Penco, Maria, Schina, A., Hübbe, M. L., Siersbæk, M., Holmström, M. O., Jørgensen, M. A., Svane, Inge Marie, Met, Özcan, Ødum, Niels, Madsen, Daniel Hargbøl, dqp123, dqp123, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 10, e005326.

      Research output: Contribution to journal › Journal article › Research › peer-review

    17. Published

      CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

      Lecoq, I., Kopp, K. L., Chapellier, M., Mantas, P., Martinenaite, E., Perez Penco, Maria, Rønn Olsen, L., Zocca, M. B., Wakatsuki Pedersen, A. & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2115655.

      Research output: Contribution to journal › Journal article › Research › peer-review

    18. Published

      Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

      Gigoux, M., Holmström, M. O., Zappasodi, R., Park, J. J., Pourpe, S., Bozkus, C. C., Mangarin, L. M. B., Redmond, D., Verma, S., Schad, S., George, M. M., Venkatesh, D., Ghosh, A., Hoyos, D., Molvi, Z., Kamaz, B., Marneth, A. E., Duke, W., Leventhal, M. J., Jan, M. & 23 others, Ho, V. T., Hobbs, G. S., Knudsen, T. A., Skov, V., Kjær, L., Larsen, T. S., Hansen, D. L., Lindsley, R. C., Hasselbalch, Hans Carl, Grauslund, J. H., Lisle, T. L., Met, Özcan, Wilkinson, P., Greenbaum, B., Sepulveda, M. A., Chan, T., Rampal, R., Andersen, Mads Hald, Abdel-Wahab, O., Bhardwaj, N., Wolchok, J. D., Mullally, A. & Merghoub, T., 2022, In: Science Translational Medicine. 14, 649, eaba4380.

      Research output: Contribution to journal › Journal article › Research › peer-review

    19. Published

      Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies

      Andersen, Mads Hald, 2022, In: Immuno Oncology Insights. 3, 9, p. 401-407

      Research output: Contribution to journal › Journal article › Research › peer-review

    20. Published

      Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression

      Carnaz Simões, A. M., Holmström, M. O., Aehnlich, P., Rahbech, Anne, Radziwon-Balicka, A., Zamora, C., Wirenfeldt Klausen, T., Skov, V., Kjær, L., Ellervik, Christina, Fassi, Daniel El , Vidal, S., Hasselbalch, Hans Carl, Andersen, Mads Hald & thor Straten, P., 2022, In: Frontiers in Immunology. 13, 866610.

      Research output: Contribution to journal › Journal article › Research › peer-review

    21. Published

      Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

      Bendtsen, S. K., Perez Penco, Maria, Hübbe, M. L., Martinenaite, E., Orebo Holmström, M., Weis-Banke, S. E., Grønne Dahlager Jørgensen, N., Jørgensen, M. A., Munir Ahmad, S., Jensen, K. M., Friese, C., Lundsager, M. T., Johansen, A. Z., Carretta, M., Ødum, Niels, Met, Özcan, Svane, Inge Marie, Madsen, Daniel Hargbøl & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2026020.

      Research output: Contribution to journal › Journal article › Research › peer-review

    22. Published

      TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer

      Perez Penco, Maria, Weis-Banke, S. E., Schina, A., Siersbæk, M., Hübbe, M. L., Jørgensen, M. A., Lecoq, I., Lara De La Torre, L., Bendtsen, S. K., Martinenaite, E., Holmström, M. O., Madsen, Daniel Hargbøl, dqp123, dqp123, Ødum, Niels, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 12, 15 p., e005491.

      Research output: Contribution to journal › Journal article › Research › peer-review

    23. Published

      Therapeutic Potential of an Immune-Modulatory Vaccination Targeting Myeloid-Derived Suppressor Cells in Myelodysplastic Syndrome

      Bentivegna, Sofia, Holmstrøm, M., Balhuizen, Alexander, Almosailleakh, M., Perez Penco, Maria, Porse, Bo Torben, Andersen, Mads Hald & Grønbæk, Kirsten, 2022, In: Blood. 140, Suppl. 1, p. 4007-4008 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research

    24. 2021
    25. Published

      Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

      Handlos Grauslund, J., Holmström, M. O., Jørgensen, N. G., Klausen, U., Weis-Banke, S. E., El Fassi, D., Schöllkopf, C., Clausen, M. B., Gjerdrum, L. M. R., Breinholt, M. F., Kjeldsen, J. W., Hansen, M., Koschmieder, S., Chatain, N., Novotny, G. W., Petersen, J., Kjær, L., Skov, V., Met, Ö., Svane, I. M. & 2 others, Hasselbalch, Hans Carl & Andersen, Mads Hald, 26 Feb 2021, In: Frontiers in Oncology. 11, 17 p., 637420.

      Research output: Contribution to journal › Journal article › Research › peer-review

    26. Published

      Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner

      Holmström, M. O., Mortensen, R. E. J., Pavlidis, A. M., Martinenaite, E., Weis-Banke, S. E., Aaboe-Jørgensen, M., Bendtsen, S. K., Met, Özcan, Pedersen, A. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, Feb 2021, In: Cellular and Molecular Immunology. 18, 2, p. 415-426 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    27. Published

      A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

      Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., dqp123, dqp123, Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, Helle Westergren, Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, Mads Hald & Svane, Inge Marie, 2021, In: Nature Medicine. 27, p. pages2212–2223

      Research output: Contribution to journal › Journal article › Research › peer-review

    28. Published

      An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

      Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.

      Research output: Contribution to journal › Journal article › Research › peer-review

    29. Published

      Arginase 1–Based immune modulatory vaccines induce anticancer immunity and synergize with Anti–PD-1 checkpoint blockade

      Jørgensen, M. A., Ugel, S., Hübbe, M. L., Carretta, M., Perez Penco, Maria, Weis-Banke, S. E., Martinenaite, E., Kopp, K., Chapellier, M., Adamo, A., de Sanctis, F., Frusteri, C., Iezzi, M., Zocca, M. B., Madsen, Daniel Hargbøl, Pedersen, A. W., Bronte, V. & Andersen, Mads Hald, 2021, In: Cancer Immunology Research. 9, 11, p. 1316-1326 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    30. Published

      Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells

      Mortensen, R. E. J., Holmström, M. O. & Andersen, Mads Hald, 2021, In: Cellular and Molecular Immunology. 18, 11, p. 2575-2577 3 p.

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    31. Published

      Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

      Rasmussen, M., Lim, K., Rambech, E., Andersen, Mads Hald, Svane, Inge Marie, Andersen, Ove, Jensen, L. H., Nilbert, Mef Christina & Therkildsen, C., 2021, In: Gynecologic Oncology. 162, 3, p. 686-693

      Research output: Contribution to journal › Journal article › Research › peer-review

    32. Published

      Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens

      Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.

      Research output: Contribution to journal › Journal article › Research › peer-review

    33. Published

      Vaccination against pd-l1 with io103 a novel immune modulatory vaccine in basal cell carcinoma: A phase iia study

      Jørgensen, N. G., Kaae, Jeanette, Grauslund, J. H., Met, Özcan, Nielsen, S. L., Pedersen, A. W., Svane, Inge Marie, Ehrnrooth, E., Andersen, Mads Hald, Zachariae, Claus & Skov, Lone, 2021, In: Cancers. 13, 4, p. 1-15 15 p., 911.

      Research output: Contribution to journal › Journal article › Research › peer-review

    34. 2020
    35. Published

      Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

      Blümel, E., Munir Ahmad, S., Nastasi, C., Willerslev-Olsen, A., Gluud, M., Fredholm, S., Hu, T., Surewaard, B. G. J., Lindahl, L. M., Fogh, H., Koralov, S. B., Rahbek Gjerdrum, L. M., Clark, R. A., Iversen, L., Krejsgaard, T., Bonefeld, C. M., Geisler, C., Becker, J. C., Woetmann, A., Andersen, M. H. & 2 others, Buus, Terkild Brink & Ødum, Niels, 2020, In: OncoImmunology. 9, 1, 9 p., 1751561.

      Research output: Contribution to journal › Journal article › Research › peer-review

    36. Published

      Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome

      Willerslev-Olsen, A., Buus, Terkild Brink, Nastasi, C., Blümel, E., Gluud, Maria, Bonefeld, Charlotte Menne, Geisler, Carsten, Lindahl, L. M., Vermeer, M., Wasik, M. A., Iversen, L., Becker, J. C., Andersen, Mads Hald, Gjerdrum, Lise Mette Rahbek, Litvinov, I. V., Litman, Thomas, Krejsgaard, T., Woetmann, Anders & Ødum, Niels, 2020, In: Blood Cancer Journal. 10, 5, 11 p., 57.

      Research output: Contribution to journal › Journal article › Research › peer-review

    37. Published

      Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms

      Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancers. 12, 7, p. 1-21 21 p., 1763.

      Research output: Contribution to journal › Review › Research › peer-review

    38. Published

      Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

      Holmström, M. O., Cordua, S., Skov, V., Kjær, L., Pallisgaard, N., Ellervik, Christina, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancer Immunology, Immunotherapy. 69, p. 315–324

      Research output: Contribution to journal › Review › Research › peer-review

    39. Published

      Healthy donors harbor memory T cell responses to RAS neo-antigens

      Holmström, M. O. & Andersen, Mads Hald, 2020, In: Cancers. 12, 10, p. 1-16 16 p., 3045.

      Research output: Contribution to journal › Journal article › Research › peer-review

    40. Published

      Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade

      Hübbe, M. L., Jæhger, D. E., Andresen, T. L. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 578349.

      Research output: Contribution to journal › Review › Research › peer-review

    41. Published

      MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas

      Gluud, Maria, Willerslev-Olsen, A., Gjerdrum, Lise Mette Rahbek, Lindahl, L. M., Buus, Terkild Brink, Andersen, Mads Hald, Bonefeld, Charlotte Menne, Krejsgaard, T., Litvinov, I. V., Iversen, L., Becker, J. C., Persson, J. L., Koralov, S. B., Litman, Thomas, Geisler, Carsten, Woetmann, Anders & Ødum, Niels, 2020, In: Cancers. 12, 5, 18 p., 1229.

      Research output: Contribution to journal › Review › Research › peer-review

    42. Published

      Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

      Jørgensen, N. G., Klausen, U., Grauslund, J. H., Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 11 p., 595035.

      Research output: Contribution to journal › Journal article › Research › peer-review

    43. Published

      Peptide vaccination directed against IDO1-expressing immune cells elicits CD8 + and CD4 + T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

      Dey, S., Sutanto-Ward, E., Kopp, K. L., Duhadaway, J., Mondal, A., Ghaban, D., Lecoq, I., Zocca, M. B., Merlo, L. M. F., Mandik-Nayak, L., Andersen, Mads Hald, Pedersen, A. W. & Muller, A. J., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 2020000605.

      Research output: Contribution to journal › Journal article › Research › peer-review

    44. Published

      The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

      Weis-Banke, S. E., Hübbe, M. L., Holmström, M. O., Jørgensen, M. A., Bendtsen, S. K., Martinenaite, E., Carretta, M., Svane, Inge Marie, Ødum, Niels, Pedersen, A. W., Met, Özcan, Madsen, D. H. & Andersen, Mads Hald, 2020, In: OncoImmunology. 9, 1, 16 p., 1771142.

      Research output: Contribution to journal › Journal article › Research › peer-review

    45. 2019
    46. Published

      Anti-cancer immunotherapy: breakthroughs and future strategies

      Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 1-3 3 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    47. Published

      Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

      Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cancer Immunology, Immunotherapy. 68, 11, p. 1901-1907 7 p.

      Research output: Contribution to journal › Review › Research › peer-review

    48. Published

      B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment

      Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M., Andersen, Mads Hald, Svane, Inge Marie, Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C. & Nielsen, C. H., 2019, In: European Journal of Haematology. 103, 4, p. 351-361 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    49. Published

      Cancer immune therapy for lymphoid malignancies: recent advances

      Klausen, U., Jorgensen, N. G. D., Grauslund, J. H., Holmstrom, M. O. & Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 111-124

      Research output: Contribution to journal › Review › Research › peer-review

    50. Published

      Cancerimmunterapi til behandling af hæmatologisk cancer

      Holmström, M. O., Klausen, U., Jørgensen, N. G., Holmberg, S., Grauslund, J., Met, Ö., Svane, Inge Marie, Pedersen, Lars Møller, Knudsen, L. M., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: Ugeskrift for Laeger. 181, 10, 5 p., V06180421.

      Research output: Contribution to journal › Journal article › Research › peer-review

    51. Published

      Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

      Hu, T., Buus, T. B., Krejsgaard, T., Nansen, A., Lundholt, B. K., Spee, P., Fredholm, S., Petersen, D. L., Blümel, E., Gluud, M., Monteiro, M. N., Willerslev-Olsen, A., Andersen, M. H., Straten, P. T., Met, Ö., Stolearenco, V., Fogh, H., Gniadecki, R., Nastasi, C., Litman, T. & 3 others, Woetmann, Anders , Gjerdrum, Lise Mette Rahbek & Ødum, Niels, 2019, In: OncoTarget. 10, 47, p. 4894-4906 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    52. Published

      High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

      Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, Inge Marie, Kjær, L., Skov, V., Ellervik, Christina, Pallisgaard, N., Hasselbalch, H. C. & Andersen, Mads Hald, 2019, In: Blood Cancer Journal. 9, 2, 8.

      Research output: Contribution to journal › Journal article › Research › peer-review

    53. Published

      Immunoprofiles of colorectal cancer from Lynch syndrome

      Walkowska, J., Kallemose, T., Jönsson, G., Jönsson, M., Andersen, Ove, Andersen, Mads Hald, Svane, Inge Marie, Langkilde, A., Nilbert, Mef Christina & Therkildsen, C., 2019, In: OncoImmunology. 8, 1, 9 p., e1515612.

      Research output: Contribution to journal › Journal article › Research › peer-review

    54. Published

      Inflammation induced PD-L1-specific T cells

      Munir, S., Lundsager, M. T., Jørgensen, M. A., Hansen, M., Petersen, T. H., Bonefeld, Charlotte Menne, Friese, C., Met, Özcan, Straten, P. T. & Andersen, Mads Hald, 2019, In: Cell Stress & Chaperones. 3, 10, p. 319-327

      Research output: Contribution to journal › Journal article › Research › peer-review

    55. Published

      MERTK Acts as a costimulatory receptor on human cd8 t cells

      Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, Mads Hald, Olofsson, G. H., Svane, Inge Marie, Rasmussen, Lene Juel, Met, Özcan, Becker, J. C., dqp123, dqp123, Desler, Claus & Straten, P. T., 2019, In: Cancer Immunology Research. 7, 9, p. 1472-1484 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    56. Published

      Neo-antigen specific memory T-cell responses in healthy individuals

      Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: OncoImmunology. 8, 7, 2 p., 1599640.

      Research output: Contribution to journal › Letter › Research › peer-review

    57. Published

      Peripheral memory T cells specific for Arginase-1

      Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    58. Published

      Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

      Holmström, M. O., Novotny, G. W., Petersen, J., Aaboe-Jørgensen, M., Hasselbalch, Hans Carl, Andersen, Mads Hald, Nielsen, S. L., Fassi, Daniel El & Schöllkopf, C., 2019, In: Leukemia and Lymphoma. 60, 13, p. 3296-3299

      Research output: Contribution to journal › Letter › Research › peer-review

    59. Published

      Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

      Blümel, E., Willerslev-Olsen, A., Gluud, Maria, Lindahl, L. M., Fredholm, S., Nastasi, C., Krejsgaard, T., Surewaard, B. G. J., Koralov, S. B., Hu, T., Persson, J. L., Bonefeld, Charlotte Menne, Geisler, Carsten, Iversen, L., Becker, J. C., Andersen, Mads Hald, Woetmann, Anders , Buus, Terkild Brink & Ødum, Niels, 2019, In: OncoImmunology. 8, 11, 7 p., e1641387.

      Research output: Contribution to journal › Journal article › Research › peer-review

    60. Published

      Terapeutisk cancervaccination mod hæmatologisk cancer

      Holmström, M. O., Grauslund, J. H., Dahlager-Jørgensen, N. G., Klausen, U., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: Ugeskrift for Laeger. 181, 20A, 5 p., V04190233.

      Research output: Contribution to journal › Journal article › Research › peer-review

    61. Published

      The T-win® technology: immune-modulating vaccines

      Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 87-95 9 p.

      Research output: Contribution to journal › Review › Research › peer-review

    62. Published

      The targeting of tumor-associated macrophages by vaccination

      Andersen, Mads Hald, 2019, In: Cell Stress & Chaperones. 3, 5, p. 139-140

      Research output: Contribution to journal › Comment/debate › Research

    63. 2018
    64. Published

      Immunoregulatory antigens-novel targets for cancer immunotherapy

      Pedersen, A. W., Kopp, K. L., Andersen, Mads Hald & Zocca, M., Apr 2018, In: Chinese Clinical Oncology. 7, 2, p. 1-8 19.

      Research output: Contribution to journal › Journal article › Research › peer-review

    65. Published

      Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

      Kjaer, L., Holmström, M. O., Cordua, S., Andersen, Mads Hald, Svane, Inge Marie, Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, Hans Carl, Apr 2018, In: Leukemia and Lymphoma. 59, 4, p. 973-977 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    66. Published

      The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

      Holmstrom, M. O., Martinenaite, E., Ahmad, S. M., Met, Özcan, Friese, C., Kjaer, L., Riley, C. H., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 1 Feb 2018, In: Leukemia. 32, 2, p. 429-437

      Research output: Contribution to journal › Journal article › Research › peer-review

    67. Published

      Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report

      Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 2018, In: Frontiers in Immunology. 9, SEP, 6 p., 2145.

      Research output: Contribution to journal › Journal article › Research › peer-review

    68. Published

      Frequent adaptive immune responses against arginase-1

      Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

      Research output: Contribution to journal › Journal article › Research › peer-review

    69. Published

      Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

      Woetmann, Anders , Alhede, M., Dabelsteen, Sally, Bjarnsholt, Thomas, Rybtke, Morten Levin, Nastasi, C., Krejsgaard, T., Andersen, Mads Hald, Bonefeld, Charlotte Menne, Geisler, Carsten, Givskov, Michael & Ødum, Niels, 2018, In: OncoTarget. 9, 28, p. 19481-19489 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    70. Published

      Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

      Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.

      Research output: Contribution to journal › Review › Research › peer-review

    71. Published

      Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

      Jørgensen, M. A., Holmström, M. O., Martinenaite, E., Riley, C. H., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 9, 8 p., e1468957.

      Research output: Contribution to journal › Journal article › Research › peer-review

    72. Published

      Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

      Holmström, M. O., Riley, C. H., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 6, e1433521.

      Research output: Contribution to journal › Journal article › Research › peer-review

    73. Published

      The balance players of the adaptive immune system

      Andersen, Mads Hald, 2018, In: Cancer Research. 78, 6, p. 1379-1382

      Research output: Contribution to journal › Review › Research › peer-review

    74. Published

      The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G

      Melsted, W. N., Matzen, S. H., Andersen, Mads Hald & Hviid, Thomas Vauvert F., 2018, In: Cellular Immunology. 324, p. 14-23

      Research output: Contribution to journal › Journal article › Research › peer-review

    75. Published

      The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

      Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Özcan, Nastasi, C., Klausen, U., dqp123, dqp123, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders , Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 2, 10 p., e1390641.

      Research output: Contribution to journal › Journal article › Research › peer-review

    76. 2017
    77. Published

      Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

      Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, Charlotte Menne, Geisler, Carsten, Andersen, Mads Hald, Ødum, Niels & Woetmann, Anders , Dec 2017, In: Scientific Reports. 7, 10 p., 14516.

      Research output: Contribution to journal › Journal article › Research › peer-review

    78. Published

      Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

      Overgaard, N. H., Frøsig, T. M., Jakobsen, J. T., Buus, Søren, Andersen, Mads Hald & Jungersen, G., Oct 2017, In: Vaccine. 35, 42, p. 5629-5636 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    79. Published

      Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

      Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, Seliger, B., Jönsson, G. & Svane, Inge Marie, 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    80. Published

      Cancer and autoimmunity

      Andersen, Mads Hald, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 241-243 3 p.

      Research output: Contribution to journal › Editorial › Research › peer-review

    81. Published

      Anti-regulatory T cells

      Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 317–326 10 p.

      Research output: Contribution to journal › Review › Research › peer-review

    82. Published

      Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

      Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.

      Research output: Contribution to journal › Journal article › Research › peer-review

    83. Published

      Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer

      Klausen, U., Andersen, Mads Hald & Pedersen, Lars Møller, 2017, In: Ugeskrift for Læger. 179, 5 p., V03170220.

      Research output: Contribution to journal › Journal article › Research › peer-review

    84. Published

      The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

      Holmstrom, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: OncoImmunology. 6, 11, 3 p., e1358334.

      Research output: Contribution to journal › Journal article › Research › peer-review

    85. Published

      The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

      Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498

      Research output: Contribution to journal › Letter › Research › peer-review

    86. Published

      The role of dendritic cells in cancer

      Hansen, M. & Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 307-316

      Research output: Contribution to journal › Review › Research › peer-review

    87. 2016
    88. Published

      GTn repeat polymorphism in heme oxygenase-1 (HO-1) correlates with clinical outcome after myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

      Køllgaard, T., Kornblit, B., Petersen, J., Klausen, T. W., Mortensen, B. K., Brændstrup, P., Sengeløv, Henrik, Høgdall, Estrid Vilma Solyom, Muller, Klaus, Vindeløv, L., Andersen, Mads Hald & thor Straten, E. P., Dec 2016, In: PLoS ONE. 11, 12, 8 p., e0168210.

      Research output: Contribution to journal › Journal article › Research › peer-review

    89. Published

      The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

      Holmström, M. O., Riley, C. H., Svane, Inge Marie, Hasselbalch, H. C. & Andersen, Mads Hald, Dec 2016, In: Leukemia. 30, 12, p. 2413-2416 14 p.

      Research output: Contribution to journal › Letter › Research › peer-review

    90. Published

      mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

      Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.

      Research output: Contribution to journal › Journal article › Research › peer-review

    91. Published

      Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

      Hansen, M., Met, Özcan, Larsen, N. B., Rosenkilde, Mette, Andersen, Mads Hald, Svane, Inge Marie & Hjortø, Gertrud Malene, Sep 2016, In: Cytotherapy. 18, 9, p. 1187-1196

      Research output: Contribution to journal › Journal article › Research › peer-review

    92. Published

      PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

      Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.

      Research output: Contribution to journal › Journal article › Research › peer-review

    93. Published

      Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

      Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    94. Published

      Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

      Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    95. Published

      PD-L1-specific T cells

      Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, Mads Hald, Jul 2016, In: Cancer Immunology, Immunotherapy. 65, 7, p. 797-804 8 p.

      Research output: Contribution to journal › Review › Research › peer-review

    96. Published

      Novel understanding of self-reactive T cells

      Andersen, Mads Hald, Mar 2016, In: OncoImmunology. 5, 3, 2 p., e1083672 .

      Research output: Contribution to journal › Editorial › Research › peer-review

    97. Published

      Anti-regulatory T cells

      Andersen, Mads Hald, 2016, Københavns Universitet.

      Research output: Book/Report › Doctoral thesis › Research

    98. Published

      CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

      Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.

      Research output: Contribution to journal › Journal article › Research › peer-review

    99. Published

      Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

      Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.

      Research output: Contribution to journal › Journal article › Research › peer-review

    100. Published

      The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

      Fredholm, S., Litvinov, I. V., Mongan, N. P., Schiele, S., Willerslev-Olsen, A., Petersen, D. L., Krejsgaard, T., Sibbesen, N., Nastasi, C., Bonefeld, Charlotte Menne, Persson, J. L., thor Straten, E. P., Andersen, Mads Hald, Koralov, S. B., Wasik, M. M., Geisler, Carsten, Sasseville, D., Woetmann, Anders & Ødum, Niels, 2016, In: Journal of Investigative Dermatology. 136, 4, p. 866-869 4 p.

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    101. 2015
    102. Published

      Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

      Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    103. Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy

      Andersen, Mads Hald, Sep 2015, In: National Cancer Institute. Journal (Online). 107, 9, p. 1-8 djv154.

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    104. Published

      Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

      Borch, T. H., Donia, M., Andersen, Mads Hald & Svane, Inge Marie, Sep 2015, In: Drug Discovery Today. 20, 9, p. 1127-34 8 p.

      Research output: Contribution to journal › Review › Research › peer-review

    105. Published

      Oncogenic cancer/testis antigens: prime candidates for immunotherapy

      Gjerstorff, M. F., Andersen, Mads Hald & Ditzel, H. J., 30 Jun 2015, In: OncoTarget. 6, 18, p. 15772-87 16 p.

      Research output: Contribution to journal › Review › Research › peer-review

    106. Published

      Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis

      Johansen, M. E., Johansson, P. I., Ostrowski, Sisse Rye, Bestle, Morten Heiberg, Hein, L., Jensen, A. L. G., Søe-Jensen, P., Andersen, Mads Hald, Steensen, M., Mohr, T., Thormar, K., Lundgren, B., Cozzi-Lepri, A., Lundgren, Jens & Jensen, J., Feb 2015, In: Seminars in Thrombosis and Hemostasis. 41, 1, p. 16-25 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    107. Published

      The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer

      Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, Jan 2015, In: Basic & Clinical Pharmacology & Toxicology. 116, 1, p. 19-24 6 p.

      Research output: Contribution to journal › Review › Research › peer-review

    108. Published

      Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

      Hjortsø, M. D., Larsen, S. K., Kongsted, P., Met, Özcan, Frøsig, T. M., Andersen, G. H., Ahmad, S. M., Svane, Inge Marie, Becker, J. C., Straten, P. T. & Andersen, Mads Hald, Jan 2015, In: OncoImmunology. 4, 1, e968480.

      Research output: Contribution to journal › Journal article › Research › peer-review

    109. Published

      Establishing the pig as a large animal model for vaccine development against human cancer

      Overgaard, N. H., Frøsig, T. M., Welner, S., Rasmussen, M., Ilsøe, M., Sørensen, M. R., Andersen, Mads Hald, Buus, Søren & Jungersen, G., 2015, In: Frontiers in Genetics. 6, 12 p., 286.

      Research output: Contribution to journal › Journal article › Research › peer-review

    110. Published

      Indoleamine 2,3-dioxygenase vaccination

      Andersen, Mads Hald & Svane, Inge Marie, 2015, In: OncoImmunology. 4, 1, p. 1-3 3 p., e983770.

      Research output: Contribution to journal › Journal article › Research › peer-review

    111. Published

      Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

      Køllgaard, T., Ugurel-Becker, S., Idorn, M., Andersen, Mads Hald, Becker, J. C. & thor Straten, E. P., 2015, In: P L o S One. 10, 7, 14 p., e0131934.

      Research output: Contribution to journal › Journal article › Research › peer-review

    112. Published

      The effect of short-chain fatty acids on human monocyte-derived dendritic cells

      Nastasi, C., Candela, M., Bonefeld, Charlotte Menne, Geisler, Carsten, Hansen, M., Krejsgaard, T., Biagi, E., Andersen, Mads Hald, Brigidi, P., Ødum, Niels, Litman, T. & Woetmann, Anders , 2015, In: Scientific Reports. 5, 10 p., 16148.

      Research output: Contribution to journal › Journal article › Research › peer-review

    113. 2014
    114. Published

      Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

      Iversen, T. Z., Engell-Noerregaard, L., Ellebaek, E., Andersen, R. S., Larsen, S. K., Bjoern, J., Zeyher, C., Gouttefangeas, C., Thomsen, B. M., Holm, B., Thor Straten, P., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 1 Jan 2014, In: Clinical Cancer Research. 20, 1, p. 221-232 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    115. Published

      Spontaneous presence of FOXO3-specific T cells in cancer patients

      Larsen, S. K., Ahmad, S. M., Idorn, M., Met, Özcan, Martinenaite, E., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 1 Jan 2014, In: OncoImmunology. 3, 8, e953411.

      Research output: Contribution to journal › Journal article › Research › peer-review

    116. 2013
    117. Published

      Functional characterization of Foxp3-specific spontaneous immune responses

      Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In: Leukemia. 27, 12, p. 2332-40 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    118. Published

      Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells

      Munir, S., Andersen, G. H., Woetmann, Anders , Ødum, Niels, Becker, J. C. & Andersen, Mads Hald, Nov 2013, In: Leukemia. 27, 11, p. 2251-3 3 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    119. Published

      HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

      Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In: Cancer Research. 73, 6, p. 1764-76 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    120. Published

      The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

      Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In: OncoImmunology. 2, 4, 9 p., e23991.

      Research output: Contribution to journal › Journal article › Research › peer-review

    121. 2012
    122. Published

      Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution

      Donia, M., Junker, N., Ellebaek, E., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2012, In: Scandinavian Journal of Immunology. 75, 2, p. 157-167 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    123. Published

      Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

      Junker, N., Kvistborg, P., Køllgaard, T., Straten, P. T., Andersen, Mads Hald & Svane, Inge Marie, 2012, In: Cellular Immunology. 273, 1, p. 1-9 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    124. 2011
    125. Submitted

      PD-L1 based Immunotherapy

      Andersen, Mads Hald, 17 Oct 2011, (Submitted) 17 Oct 2011

      Research output: Patent

    126. Published

      Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial

      Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., Tousi, H., Søe-Jensen, P., Lauritsen, A. Ø., Strange, D., Petersen, P. L., Reiter, N., Hestad, S., Thormar, K., Fjeldborg, P., Larsen, K. M. & 6 others, Drenck, N. E., Ostergaard, C., Kjær, J., Grarup, J., Lundgren, Jens & Procalcitonin And Survival Study (PASS) Group, P. A. S. S. (. G., 1 Sep 2011, In: Critical Care Medicine. 39, 9, p. 2048-58 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    127. Published

      Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

      Straten, P. T. & Andersen, Mads Hald, 12 May 2011, In: Vaccine. 29, 21, p. 3728

      Research output: Contribution to journal › Journal article › Research › peer-review

    128. Published

      Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

      Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Buchwald, C. V., Andersen, E., Straten, P. T., Svane, Inge Marie & Andersen, Mads Hald, 24 Mar 2011, In: Cytotherapy. 13, 7, p. 822-34

      Research output: Contribution to journal › Journal article › Research › peer-review

    129. Published

      Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2

      Sørensen, R. B., Køllgaard, T., Andersen, R. S., van den Berg, J. H., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 15 Mar 2011, In: Cancer Research. 71, 6, p. 2038-44 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    130. Published

      Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

      Sørensen, R. B., Hadrup, S. R., Svane, Inge Marie, Hjortsø, M. C., Thor Straten, P., Andersen, Mads Hald, Hjortsø, M. C. & Andersen, Mads Hald, 17 Feb 2011, In: Blood. 117, 7, p. 2200-10 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    131. Published

      A potential role of indoleamine 2,3-dioxygenase-specific T cells in leishmania vaccination

      thor Straten, P. & Andersen, Mads Hald, 2011, In: Journal of Infectious Diseases. 204, 3, p. 488-9 2 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    132. Published

      Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

      Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., von Buchwald, Christian, Andersen, E., Straten, P. T. & Svane, Inge Marie, 2011, In: Cytotherapy. 13, 7, p. 822-34 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    133. Published

      Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

      Bjoern, J., Brimnes, M. K., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2011, In: Scandinavian Journal of Immunology. 73, 3, p. 222-33 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    134. Published

      Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

      Junker, N., Thor Straten, P., Andersen, Mads Hald & Svane, Inge Marie, 2011, In: Journal of Skin Cancer. 2011, 574695, 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    135. Published

      HLA-A2-restricted survivin-derived T-cell responses

      Straten, P. T. & Andersen, Mads Hald, 2011, In: Vaccine. 29, 52, p. 9582

      Research output: Contribution to journal › Letter › Research › peer-review

    136. Published

      Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

      Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    137. Submitted

      IkB based Immunotherapy

      Andersen, Mads Hald, 2011, (Submitted) 26 Oct 2011

      Research output: Patent

    138. 2010
    139. Published

      Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

      Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, Mads Hald, Pedersen, Anders Elm, Soleimani, A., Lorentzen, T., Johansen, Julia Sidenius & Svane, Inge Marie, 1 Oct 2010, In: Cytotherapy. 12, 6, p. 721-34 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    140. Published

      The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens

      Straten, P. T., Andersen, Mads Hald & Andersen, Mads Hald, 1 Aug 2010, In: OncoTarget. 1, 4, p. 239-45 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    141. Published

      Therapeutic cancer vaccines in combination with conventional therapy

      Andersen, Mads Hald, Junker, N., Ellebaek, E., Svane, Inge Marie, Thor Straten, P. & Andersen, Mads Hald, 1 Jan 2010, In: Journal of Biomedicine and Biotechnology. 2010, p. 237623

      Research output: Contribution to journal › Journal article › Research › peer-review

    142. Published

      Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

      Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    143. Published

      Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

      Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    144. Published

      Spontaneous Cytotoxic T cell Reactivity Against IDO Exists in Cancer Patients and in Healthy Donors

      Sørensen, R. B., Straten, P. T., Andersen, Mads Hald & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 910-911 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    145. Published

      Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

      Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    146. Published

      Therapeutic cancer vaccines

      Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174

      Research output: Contribution to journal › Journal article › Research › peer-review

    147. 2009
    148. Published

      Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56

      Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, S., Becker, J. C., Thor Straten, P., Andersen, Mads Hald, Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, Søren, Becker, J. C., Thor Straten, P. & Andersen, M. H., 1 Aug 2009, In: Journal of Investigative Dermatology. 129, 8, p. 1992-9 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    149. Published

      CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

      Sørensen, R. B., Andersen, R. S., Svane, Inge Marie, Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, Mads Hald & thor Straten, P., 2009, In: Clinical Cancer Research. 15, 5, p. 1543-9 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    150. Published

      Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"

      Sørensen, R. B., thor Straten, P. & Andersen, Mads Hald, 2009, In: Journal of Immunology. 183, 10, p. 6040 1 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    151. Published

      Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

      Hofmann, U. B., Voigt, H., Andersen, Mads Hald, Straten, P. T., Becker, J. C. & Eggert, A. O., 2009, In: European Journal of Immunology. 39, 5, p. 1419-24 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    152. Published

      Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

      Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    153. Published

      Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

      Hofmeister-Mueller, V., Vetter-Kauczok, C. S., Ullrich, R., Meder, K., Lukanidin, E., Broecker, E., Straten, P. T., Andersen, Mads Hald, Schrama, D. & Becker, J. C., 2009, In: Cancer Immunology, Immunotherapy. 58, 8, p. 1265-73 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    154. Published

      Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)

      Køllgaard, T., Duval, L., Schmidt, H., Kaltoft, K., Seremet, T., Andersen, Mads Hald, Maase, H. V. D., Straten, P. T. & Hadrup, S. R., 2009, In: Cytotherapy. 11, 5, p. 631-41 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    155. Published

      Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

      Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    156. Published

      The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

      Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: PLoS ONE. 4, 9, p. e6910

      Research output: Contribution to journal › Journal article › Research › peer-review

    157. Published

      The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

      Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: Cancer Immunology, Immunotherapy. 58, 5, p. 665-75 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 13571778